Melatonin for treatment of sleeping disorders in children with attention deficit/hyperactivity disorder: a preliminary open label study.
Tjon Pian Gi
Cecil V
CV
Department of Paediatrics, Groene Hart Ziekenhuis, 1098, 2800, Gouda, The Netherlands. cecil.tjonpiangi@ghz.nl.
Broeren
Joris P A
JPA
Department of Paediatrics, Groene Hart Ziekenhuis, 1098, 2800, Gouda, The Netherlands.
Starreveld
J Sander
JS
Department of Paediatrics, Groene Hart Ziekenhuis, 1098, 2800, Gouda, The Netherlands.
A Versteegh
Florens G
FG
Department of Paediatrics, Groene Hart Ziekenhuis, 1098, 2800, Gouda, The Netherlands.
D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications* / Q000188:drug therapy; D002492:Central Nervous System Depressants / Q000627:therapeutic use*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D002940:Circadian Rhythm / Q000187:drug effects; D006801:Humans; D008550:Melatonin / Q000494:pharmacology / Q000627:therapeutic use*; D008774:Methylphenidate / Q000627:therapeutic use; D012890:Sleep / Q000187:drug effects; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy* / Q000209:etiology*
D002492:Central Nervous System Depressants; D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D008550:Melatonin